U.S. Specialty Stores Stock News

In March 2026, Prologis, Inc. and GIC announced a US$1.60 billion joint venture to develop and own build-to-suit logistics facilities across major U.S. markets, anchored by an initial 4.10 million-square-foot portfolio and additional capacity for future investments. The venture, housed within Prologis Strategic Capital, deepens the company’s role as an asset manager by pairing its development and operating platform with long-term institutional capital and demand-driven, pre-leased...

Figure Technology Solutions: Event Driven Snapshot Figure Technology Solutions (FIGR) has drawn fresh attention after a strong single day move, with the stock up about 11% over the latest session, in contrast with weaker year to date performance. See our latest analysis for Figure Technology Solutions. The sharp 10.55% 1 day share price return sits within a mixed picture, with a 34.30% 30 day share price return but a 22.38% year to date decline, which hints at improving short term momentum...

If you are wondering whether Alamo Group's current share price still offers value, it helps to step back and look at what the recent moves might be telling you about expectations built into the stock. The shares recently closed at US$164.97, with returns of 3.7% decline over 7 days, 22.7% decline over 30 days, 3.2% decline year to date, 7.6% decline over 1 year, 4.9% decline over 3 years, and 6.6% gain over 5 years. Taken together, this gives you a mixed picture of how the market has priced...

nCino (NCNO) returned to investors’ radar after reporting results that exceeded its own guidance, supported by 17% Annual Contract Value growth, broader AI adoption across its platform, and a stronger US enterprise sales quarter. See our latest analysis for nCino. Despite the strong earnings beat, fresh guidance and share repurchase announcement, the 1-day share price return of 3.88% and 7-day share price return of 3.88% come after a 90-day share price return decline of 41.58% and a 1-year...

In the most recent quarter, Fresh Del Monte Produce delivered an exceptional Q4, surpassing analyst estimates on earnings per share and gross margins through firm pricing, sustained demand in core categories, and tight cash flow management. This strong execution across the business highlights how disciplined pricing and cash generation can strengthen the company’s financial profile even in a challenging cost backdrop. Next, we’ll examine how this earnings beat and margin strength might...

The United States market has remained flat over the last week but is up 16% over the past year, with earnings anticipated to grow by 15% annually. In this environment, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities, particularly when insider activity suggests confidence in a company's future prospects.

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue and earnings expansion in alignment with these broader market trends.

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying stocks that are trading at a discount can offer potential opportunities for investors seeking value in a growing market.

In the last week, the United States market has stayed flat, yet it has risen by 16% over the past year with expectations of a 15% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be advantageous as they often align management interests with shareholder value and may capitalize on favorable market conditions.

The market remained flat over the last week, but it is up 16% over the past year, with earnings expected to grow by 15% annually in the coming years. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value and potential for growth. By focusing on stocks with strong financial foundations, investors may find opportunities that combine stability with promising prospects.

Over the last 7 days, the United States market has remained flat, yet it boasts a notable 16% rise over the past year with earnings forecasted to grow by 15% annually. In such a dynamic environment, discovering promising small-cap stocks that have potential for growth can be key to capitalizing on these positive trends.

Over the last 7 days, the United States market has remained flat, though it has experienced a robust 16% increase over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context of steady growth and positive earnings projections, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking reliable income streams.

This article examines whether Olin, at around US$29.73, is attractively valued or already reflects its underlying story by exploring what the current valuation suggests about the stock. The share price performance is mixed, with returns of 7.8% over 7 days, 17.2% over 30 days, 38.0% year to date and 29.5% over 1 year, while longer horizons show a 42.6% decline over 3 years and a 16.9% decline over 5 years. Recent coverage has placed less emphasis on headline-grabbing events and more on how...

If you are wondering whether Guardian Pharmacy Services at US$37.66 is priced for opportunity or already reflecting high expectations, the valuation picture is the key place to focus next. The stock has posted returns of 0.2% over the last 7 days, 12.4% over the last 30 days, 27.5% year to date and 79.2% over the past year. This naturally raises questions about how much of the story is already in the price. Recent news coverage has centered on Guardian Pharmacy Services as a healthcare name...

With the business potentially at an important milestone, we thought we'd take a closer look at Iterum Therapeutics...

MSCI (NYSE:MSCI) plans to reclassify Greece from Emerging Market to Developed Market status in its equity indexes. The company is also partnering with Syntax Data to expand its ADR index offerings for financial advisers in the US. These changes affect how global capital is allocated to Greek equities and how advisers access international exposure through US listed securities. MSCI is best known for its global equity indexes that many asset managers and ETFs use as benchmarks, so its country...

In March 2026, Signet Jewelers reported fourth-quarter sales of US$2,345.1 million and net income of US$250.0 million, alongside a higher full-year profit, while also raising its quarterly dividend to US$0.35 per share and continuing share repurchases. The sharp year-on-year jump in earnings per share, combined with a nearly double-digit dividend increase and ongoing buybacks, underscores management’s confidence in the company’s financial position and cash-generation capacity. We’ll now...

In March 2026, Neurocrine Biosciences presented new expert consensus recommendations and fresh INGREZZA (valbenazine) data on older adults with tardive dyskinesia at the PALTC26 conference in Anaheim, highlighting care challenges in long-term care settings. The company underscored INGREZZA’s differentiated clinical profile for seniors, including no required dose titration and a sprinkle formulation, alongside patient-reported improvements in symptoms, quality of life and functional...

We can readily understand why investors are attracted to unprofitable companies. For example, Annexon ( NASDAQ:ANNX...

Earnings results bring Precigen’s 2025 performance into focus Precigen (PGEN) recently reported full year 2025 results, with revenue of US$9.68 million and a net loss of US$250.64 million. The wider loss and revenue figures are likely central to how investors reassess the stock. See our latest analysis for Precigen. Precigen’s share price has been volatile, with a 1 day share price return of 19.08% and 7 day return of 23.64%, while the 90 day return shows a decline of 7.42%. This contrasts...

Creative Medical Technology Holdings, Inc. ( NASDAQ:CELZ ) is possibly approaching a major achievement in its business...

Potential LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders may wish to note that the President, Evert...

The market seemed underwhelmed by the solid earnings posted by Adobe Inc. ( NASDAQ:ADBE ) recently. Along with the...

Market forces rained on the parade of MeiraGTx Holdings plc ( NASDAQ:MGTX ) shareholders today, when the analysts...